Hypothyroidism
|
0.010 |
Biomarker
|
disease |
BEFREE |
Low T4 was observed in preterm infants irrespective of the cause of preterm birth, while maternal (TSH) and placental (DiO2, DiO3, and MCT10) compensatory responses were only activated in indicated preterm birth due to vascular complications.
|
29557697 |
2019 |
Cataract
|
0.010 |
Biomarker
|
disease |
BEFREE |
Interestingly, the absence of LAT2 led to increased incidence of cataract in mice, in particular in older females, and a synergistic effect was observed with simultaneous lack of TAT1.
|
31231240 |
2019 |
Carcinoma of urinary bladder, invasive
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ) - 2019 Update.
|
31443960 |
2019 |
Mental Depression
|
0.010 |
Biomarker
|
disease |
BEFREE |
Thirty-nine patients with depression were randomly assigned to immediate MCT (10 sessions) or a 10-week wait list period (WL).
|
28174547 |
2017 |
Depressive disorder
|
0.010 |
Biomarker
|
disease |
BEFREE |
Thirty-nine patients with depression were randomly assigned to immediate MCT (10 sessions) or a 10-week wait list period (WL).
|
28174547 |
2017 |
Euthyroid Sick Syndromes
|
0.010 |
Biomarker
|
disease |
BEFREE |
Herein, we aimed to evaluate the central and peripheral expression of genes involved in the transport (MCT8/<i>Slc16a2</i> and MCT10/<i>Slc16a10</i>), metabolism (<i>Dio1, Dio2</i>, and <i>Dio3</i>) and action (<i>Thra</i> and <i>Thrb</i>) of TH during NTIS induced by fasting or sepsis.
|
29118715 |
2017 |
Septicemia
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
CLP induced sepsis resulted in reduced: (1) T<sub>4</sub> serum levels; (2) <i>Dio1, Slc16a2, Slc16a10, Thra</i>, and <i>Thrb</i> expression in liver as well as <i>Slc16a2</i> expression in the thyroid gland (3) <i>Thrb</i> and <i>Tshb</i> mRNA expression in the pituitary; (4) total leukocyte counts in the bone marrow while increased its number in peritoneal and pleural fluids.
|
29118715 |
2017 |
Sepsis
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
CLP induced sepsis resulted in reduced: (1) T<sub>4</sub> serum levels; (2) <i>Dio1, Slc16a2, Slc16a10, Thra</i>, and <i>Thrb</i> expression in liver as well as <i>Slc16a2</i> expression in the thyroid gland (3) <i>Thrb</i> and <i>Tshb</i> mRNA expression in the pituitary; (4) total leukocyte counts in the bone marrow while increased its number in peritoneal and pleural fluids.
|
29118715 |
2017 |
Depressed mood
|
0.010 |
Biomarker
|
phenotype |
BEFREE |
Thirty-nine patients with depression were randomly assigned to immediate MCT (10 sessions) or a 10-week wait list period (WL).
|
28174547 |
2017 |
Malignant neoplasm of urinary bladder
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Focusing on patients with TaT1 non-muscle invasive BCa, BCL2L12 expression levels were correlated with higher recurrence rate at the first follow-up cystoscopy and were unveiled to be an independent unfavorable predictor of patients' short-term recurrence following transurethral resection.
|
23790536 |
2014 |
Bladder Neoplasm
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Focusing on patients with TaT1 non-muscle invasive BCa, BCL2L12 expression levels were correlated with higher recurrence rate at the first follow-up cystoscopy and were unveiled to be an independent unfavorable predictor of patients' short-term recurrence following transurethral resection.
|
23790536 |
2014 |
Drug habituation
|
0.010 |
Biomarker
|
phenotype |
BEFREE |
Tat1-86 induced developmental neurotoxic effects, as witnessed by delays in eye opening, delays in early reflex development and alterations in prepulse inhibition (PPI) and between-session habituation of locomotor activity.
|
25285887 |
2014 |
Seizures
|
0.010 |
GeneticVariation
|
phenotype |
BEFREE |
Overall, the neurotoxic profile of Tat1-86 appeared more profound in the developing nervous system in vivo relative to that seen with the first exon encoded Tat1-72 (Fitting et al., 2008b), as noted on measures of eye opening, righting reflex, and PPI.
|
25285887 |
2014 |
Carcinoma of bladder
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Focusing on patients with TaT1 non-muscle invasive BCa, BCL2L12 expression levels were correlated with higher recurrence rate at the first follow-up cystoscopy and were unveiled to be an independent unfavorable predictor of patients' short-term recurrence following transurethral resection.
|
23790536 |
2014 |
Low T3 Syndrome
|
0.010 |
Biomarker
|
disease |
BEFREE |
We examined the role of TH transporters monocarboxylate transporter 8 (MCT8, also known as SLC16A2) and MCT10 in the pathogenesis of the low T(3) syndrome in prolonged critical illness.
|
19439506 |
2009 |
nervous system disorder
|
0.010 |
Biomarker
|
group |
BEFREE |
Together, these results demonstrate that the neurotoxic epitope of Tat(1-72) is different from the epitope that is indirectly neurotoxic following production of TNF-alpha from immune cells, and suggest that therapeutic interventions against TNF-alpha might be beneficial against HIV-1 associated neurological disorders.
|
17451964 |
2007 |
Transitional cell carcinoma of bladder
|
0.010 |
Biomarker
|
disease |
BEFREE |
Association of PAX5 expression with clinical outcome in patients with TaT1 transitional cell carcinoma of the bladder.
|
16566978 |
2006 |
Malignant neoplasm of prostate
|
0.010 |
Biomarker
|
disease |
BEFREE |
Expression of tumor-associated trypsinogens (TAT-1 and TAT-2) in prostate cancer.
|
15651064 |
2005 |
Prostate carcinoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
Expression of tumor-associated trypsinogens (TAT-1 and TAT-2) in prostate cancer.
|
15651064 |
2005 |
Malignant Neoplasms
|
0.010 |
Biomarker
|
group |
BEFREE |
DNA cytometric features in biopsies of TaT1 urothelial cell cancer predict recurrence and stage progression more accurately than stage, grade, or treatment modality.
|
12809927 |
2003 |
Carcinoma
|
0.010 |
Biomarker
|
group |
BEFREE |
Proliferation markers and DNA content analysis in urinary bladder TaT1 urothelial cell carcinomas: identification of subgroups with low and high stage progression risks.
|
12783972 |
2003 |
Primary malignant neoplasm
|
0.010 |
Biomarker
|
group |
BEFREE |
DNA cytometric features in biopsies of TaT1 urothelial cell cancer predict recurrence and stage progression more accurately than stage, grade, or treatment modality.
|
12809927 |
2003 |
Lymphoma, Follicular
|
0.010 |
Biomarker
|
disease |
BEFREE |
A spontaneously EBV transformed follicular lymphoma (FL) cell line, Tat-1, was established from the lymph node biopsy specimen of a patient with B cell FL, grade 1 in transformation to high grade disease.
|
11840295 |
2002 |
Human immunodeficiency virus (HIV) II infection category B1
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Activity of human immunodeficiency virus type 1 promoter/TAR regions and tat1 genes derived from individuals with different rates of disease progression.
|
9191845 |
1997 |
Neoplasms
|
0.020 |
Biomarker
|
group |
BEFREE |
The RNA expression of PAX5 was evaluated with reverse transcriptase polymerase chain reaction in the tumor tissue of 75 patients with stage TaT1 bladder cancer treated with transurethral resection.
|
16566978 |
2006 |